Transforming Cancer Care: ONCO and Inspirata Collaborate to Leverage AI/NLP for Enhanced Registry Solutions

TAMPA, Fla., Jan. 16, 2025 /PRNewswire/ — ONCO Inc. (“ONCO”) and Inspirata Inc. (“Inspirata”) have announced a strategic partnership to advance oncology data management and support innovative cancer care solutions. Drawing on decades of combined experience in oncology informatics, this collaboration integrates their products into a streamlined, AI-driven, and scalable platform to enhance cancer registries, patient navigation, and clinical trial matching.

By uniting ONCO’s cancer registry solutions with Inspirata’s artificial intelligence (AI) and natural language processing (NLP) technologies, the partnership delivers a robust framework for improved cancer data collection, management, and analytics. Healthcare providers will benefit from greater data accuracy, compliance, and streamlined operations, underscoring both companies’ commitment to empowering cancer registries and clinicians with effective solutions for oncology care.

“As cancer data management becomes increasingly complex, our partnership with Inspirata allows us to modernize oncology data management by embedding advanced AI and NLP capabilities,” said Jim Hendrickson, Co-CEO at ONCO. “With a shared vision and unified product roadmap, we aim to deliver a streamlined user experience that addresses key industry challenges, including workforce shortages and the growing demand for high-quality data.”

The partnership integrates Inspirata’s trusted E-Path suite of products, renowned for AI/NLP-driven unstructured data processing, with ONCO’s widely adopted OncoLog platform for cancer registry management. This interoperability enables efficient case finding, automated data extraction, and comprehensive registry data capture and reporting—essential for reducing manual workloads and improving operational efficiency.

“Our partnership with ONCO underscores our commitment to leveraging AI and NLP to improve oncology care,” said Satish Sanan, CEO at Inspirata. “By combining expertise and aligning on a shared roadmap, we address workforce shortages by automating data extraction, allowing registrars to focus on higher-value activities. This collaboration equips cancer centers with advanced tools to enhance data quality, accelerate critical information access, and improve patient outcomes and research efficiency.”

ONCO and Inspirata are actively integrating their solutions at healthcare facilities to streamline workflows and enhance cancer registry processes. With seamless system compatibility, robust data integration, and AI-powered automation, this partnership delivers a cohesive, scalable solution to meet the evolving needs of oncology care today and in the future.

For more information on this partnership, visit https://www.oncoinc.com/ and https://www.inspirata.com/

Media Contacts: ONCO Heidi Hendrickson Co-CEO & President of Sales and Professional Services 
hhendrickson@oncolog.com

Inspirata 
Laura Eschen 
Marketing Director 
leschen@inspirata.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/transforming-cancer-care-onco-and-inspirata-collaborate-to-leverage-ainlp-for-enhanced-registry-solutions-302353325.html

SOURCE Inspirata

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

21 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

21 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

21 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

21 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

21 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

21 hours ago